Results vary according to skin type, sun exposure, hormonal factors, compliance
In general, the longer-acting GLP-1 agonists which are injected weekly, such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro), are associated with greater weight loss than the shorter-acting GLP-1 agonists such as liraglutide (Saxenda)
It also slows gastric emptying, which contributes to decreased postprandial glycemic excursions
FDA Peptide Reclassification: Common Questions What did the FDA do to peptides in 2026
Fifth, the population included in this study was only Japanese
Interestingly, vitreous VEGF levels do not correlate with serum VEGF, nor do plasma cytokine levels reflect those in the vitreous or aqueous humour [45,46,47]